Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Outlook Therapeutics, Inc. OTLK

Full chart Compare
Set alert

Price alert · OTLK

All alert types
0.46 USD 0.00 (+0.46%)

At closeNov 4, 2026, 6:09 PM EST

0.46 -0.01 -1.41%

After hours · Nov 4, 6:09 PM ET

0.4447 Day range 0.4779
0.161 52-week range 2.54
YTD
-70.75%
1 year
-61.81%

Financial health

Altman Z-Score

-41.26 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.6×
FY 2016: -1.2×FY 2017: -0.8×FY 2018: -0.8×FY 2019: -0.8×FY 2020: -1.1×FY 2021: -6.2×FY 2022: -3.9×FY 2023: -0.9×FY 2024: -1.3×FY 2025: -0.6×
FY 2016 5y median -1.3× FY 2025
P/S 19.1×
FY 2016: 20.5×FY 2017: 8.6×FY 2018: 7.8×FY 2019: 3.3×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 19.1×
FY 2016 5y median 0.0× FY 2025
P/B -0.8×
FY 2016: -11.8×FY 2017: -1.1×FY 2018: -1.2×FY 2019: -2.5×FY 2020: 18.5×FY 2021: 71.9×FY 2022: 29.6×FY 2023: -3.8×FY 2024: -1.4×FY 2025: -0.8×
FY 2016 5y median -0.8× FY 2025
P/FCF -0.5×
FY 2016: -1.3×FY 2017: -2.1×FY 2018: -0.7×FY 2019: -0.8×FY 2020: -1.6×FY 2021: -6.1×FY 2022: -4.6×FY 2023: -1.3×FY 2024: -1.4×FY 2025: -0.5×
FY 2016 5y median -1.4× FY 2025
EV/EBITDA -0.8×
FY 2016: -1.4×FY 2017: -1.6×FY 2018: -1.7×FY 2019: -1.1×FY 2020: -1.4×FY 2021: -6.3×FY 2022: -3.9×FY 2023: -1.2×FY 2024: -1.6×FY 2025: -0.8×
FY 2016 5y median -1.6× FY 2025
EV/Sales 34.7×
FY 2016: 22.7×FY 2017: 12.6×FY 2018: 14.4×FY 2019: 4.2×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 34.7×
FY 2016 5y median 0.0× FY 2025
FCF Yield -191.9%
FY 2016: -76.1%FY 2017: -48.0%FY 2018: -148.3%FY 2019: -120.7%FY 2020: -60.9%FY 2021: -16.4%FY 2022: -21.9%FY 2023: -77.7%FY 2024: -69.5%FY 2025: -191.9%
FY 2016 5y median -69.5% FY 2025

Profitability

Gross Margin 46.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -192.2%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 46.5%
FY 2016 5y median 0.0% FY 2025
Operating Margin -4744.3%
FY 2016: -1723.1%FY 2017: -941.2%FY 2018: -960.0%FY 2019: -445.6%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -4744.3%
FY 2016 5y median 0.0% FY 2025
Net Margin -4416.2%
FY 2016: -1788.7%FY 2017: -1019.1%FY 2018: -974.5%FY 2019: -423.8%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -4416.2%
FY 2016 5y median 0.0% FY 2025
ROE 193.9%
FY 2016: 1025.0%FY 2017: 126.4%FY 2018: 144.6%FY 2019: 320.6%FY 2020: -1247.0%FY 2021: -1154.0%FY 2022: -756.0%FY 2023: 408.5%FY 2024: 103.1%FY 2025: 193.9%
FY 2016 5y median 103.1% FY 2025
ROIC -2357.6%
FY 2016: -543.6%FY 2017: 1196.9%FY 2018: -306.7%FY 2019: -394.5%FY 2020: -273.6%FY 2021: -303.7%FY 2022: -319.3%FY 2023: -251.5%FY 2024: -455.0%FY 2025: -2357.6%
FY 2016 5y median -319.3% FY 2025
ROA -335.9%
FY 2016: -224.8%FY 2017: -187.4%FY 2018: -135.0%FY 2019: -201.5%FY 2020: -178.6%FY 2021: -233.1%FY 2022: -231.5%FY 2023: -182.6%FY 2024: -261.5%FY 2025: -335.9%
FY 2016 5y median -233.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -42.9%FY 2017: 27.9%FY 2018: -19.0%FY 2019: 163.8%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 6.5%
FY 2016: -10.3%FY 2017: 30.1%FY 2018: 17.4%FY 2019: -22.4%FY 2020: 3.7%FY 2021: -47.9%FY 2022: -21.9%FY 2023: 15.8%FY 2024: -35.0%FY 2025: 6.5%
FY 2016 FY 2025
EPS (diluted) 55.9%
FY 2016: -4.1%FY 2017: 51.0%FY 2018: 70.5%FY 2019: 53.4%FY 2020: 66.0%FY 2021: 48.0%FY 2022: 11.0%FY 2023: 23.0%FY 2024: 15.4%FY 2025: 55.9%
FY 2016 FY 2025
Free Cash Flow 24.7%
FY 2016: -28.4%FY 2017: 66.1%FY 2018: -126.8%FY 2019: 8.6%FY 2020: 2.9%FY 2021: -70.7%FY 2022: -4.5%FY 2023: 24.2%FY 2024: -60.1%FY 2025: 24.7%
FY 2016 FY 2025

Financial Health

Current Ratio 0.4×
FY 2016: 0.3×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.7×FY 2020: 1.1×FY 2021: 3.2×FY 2022: 1.4×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.4×
FY 2016 5y median 0.7× FY 2025
Quick Ratio 0.3×
FY 2016: 0.3×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.7×FY 2020: 1.1×FY 2021: 3.2×FY 2022: 1.4×FY 2023: 0.7×FY 2024: 0.6×FY 2025: 0.3×
FY 2016 5y median 0.7× FY 2025
Debt / Equity -0.9×
FY 2016: -1.7×FY 2017: -0.6×FY 2018: -1.1×FY 2019: -1.4×FY 2020: 3.1×FY 2021: 2.6×FY 2022: 1.3×FY 2023: -2.5×FY 2024: -0.4×FY 2025: -0.9×
FY 2016 5y median -0.4× FY 2025
Net Debt / EBITDA -0.3×
FY 2016: -0.1×FY 2017: -0.5×FY 2018: -0.8×FY 2019: -0.2×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: -0.2×FY 2024: -0.2×FY 2025: -0.3×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -237×
FY 2016: -27.7×FY 2017: -6.4×FY 2018: -7.6×FY 2019: -10.5×FY 2020: -19.9×FY 2021: -55.3×FY 2022: -42.4×FY 2023: -21.0×FY 2024: -22.7×FY 2025: -237×
FY 2016 5y median -42.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 51609.7%FY 2018: 7814342.9%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -43720.6%FY 2018: -6270586.9%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30